ASTH
Astrana Health, Inc.Healthcare · $1.7B market cap
Verdict
Share price
$35.88
close of Oct 3, 2026
Fair value
$45.43
Sticker Price
Payback Price
$18.17
buy price
ASTH is Undervalued: at $35.88 it trades 21% below its fair value of $45.43. Its buy price (Payback Price) is $18.17, 49% below today's price. Business quality is strong: 4 of 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
4 of 5 clear the 10% bar. What are the Big Five?
Follow ASTH
Get notified when it reaches its buy price of $18.17. Free.
Create a free accountInsider activity
Since Jun 27, 2026: no open-market purchases and 7 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
Basho Chandan
COO and CFO · 2026-09-05
Tax withholding
$69K
Sim Brandon
CEO and President · 2026-09-05
Tax withholding
$276K
Kitayama Mitchell W
director · 2026-08-31
D-Return
$315K
Schmidt David
director · 2026-08-14
D-Return
$772K
Schmidt David
director · 2026-08-14
Option exercise
$100K
Show all 7 other filingsShow fewer
Sobotka Glenn
Owns 10%+ · 2026-08-07
D-Return
11,793 shares
Sim Brandon
CEO and President · 2026-06-27
Tax withholding
$49K
About Astrana Health, Inc.
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care…
Medical - Care Facilities
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works